Anti Virals for Corona Viruses

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Companies pledge not to be caught empty handed again. Anti virals for corona viruses are task number one, says n ih director francis collins. But initiativet certainly was intended to stretch to other viral families if the funds are available. Some big pharmacutical companies are ramping up their internal efforts.

Despite warnings, and a number of close calls, drugmakers failed to develop and stockpile drugs to fight a viral pandemic. Now, in the wake of SARS-CoV-2, they are pledging not to make the same mistake again.

Around the world, researchers are racing to develop drugs to target COVID-19, but also broad-spectrum antivirals that could be used to treat future viral threats.

This is an audio version of our feature: The race for antiviral drugs to beat COVID — and the next pandemic

Hosted on Acast. See acast.com/privacy for more information.